203 related articles for article (PubMed ID: 4307562)
1. The urinary excretion of inorganic pyrophosphate in hyperparathyroidism, hyperthyroidism, Paget's disease and other disorders of bone metabolism.
Russell RG; Hodgkinson A
Clin Sci; 1969 Jun; 36(3):435-43. PubMed ID: 4307562
[No Abstract] [Full Text] [Related]
2. [Valve and significance of urinary hydroxyproline in osseous pathology].
Hioco D; Gruson M; Ryckewaert A; de Sèze S
Ann Biol Clin (Paris); 1967; 25(5):725-34. PubMed ID: 6059731
[No Abstract] [Full Text] [Related]
3. [Hydroxyprolinuria in skeletal diseases: its correlation with other parameters of bone metabolism].
Courvoisier B; Zender R
Schweiz Med Wochenschr; 1972 Feb; 102(5):160-6. PubMed ID: 5010800
[No Abstract] [Full Text] [Related]
4. Urinary hydroxylysine and hydroxylysyl glycoside excretions in normal and pathologic states.
Askenasi R
J Lab Clin Med; 1974 Apr; 83(4):673-9. PubMed ID: 4817787
[No Abstract] [Full Text] [Related]
5. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
Garnero P; Gineyts E; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
[TBL] [Abstract][Full Text] [Related]
6. [The significance of the excretion of amino acids and acid mucopolysaccharides in the urine in orthopedic diseases].
Kaiser G; Kyselka R; Mühlbach R; Hirthe D; Beck O; Schramm G; Lindenhayn K
Beitr Orthop Traumatol; 1969 Oct; 16(10):545-52. PubMed ID: 4246720
[No Abstract] [Full Text] [Related]
7. Relationship between bone uptake of 99mTc-pyrophosphate and hydroxyproline in blood and urine.
Wiegmann T; Kirsh J; Rosenthall L; Kaye M
J Nucl Med; 1976 Aug; 17(8):711-4. PubMed ID: 180269
[TBL] [Abstract][Full Text] [Related]
8. [Deoxypyridinoline and other biochemical markers of bone resorption in distinct pathologies].
Rivero Marcotegui A; Palacios Sarrasqueta M; Grijalba Uche A; Martínez Rodríguez JL; Sorbet Zubiría MJ; García Merlo S
Rev Clin Esp; 1997 Jun; 197(6):389-92. PubMed ID: 9304127
[TBL] [Abstract][Full Text] [Related]
9. [Study of urinary hydroxyproline in osteopathies].
Kocher P
Pathol Biol; 1966 Nov; 14(21):1020-39. PubMed ID: 5339820
[No Abstract] [Full Text] [Related]
10. Urinary polypeptides related to collagen synthesis.
Krane SM; Muñoz AJ; Harris ED
J Clin Invest; 1970 Apr; 49(4):716-29. PubMed ID: 4315304
[TBL] [Abstract][Full Text] [Related]
11. [Urinary hydroxyproline correlated with quantitative bone histological data. Attempted physiopathological interpretation].
Lejeune E; Meunier P; Ruitton P; Orgiazzi J
Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):107-13. PubMed ID: 4343436
[No Abstract] [Full Text] [Related]
12. [The role of the urinary hydroxyproline level in the screening for collagen diseases].
Gambella GR; Zunino M
Minerva Med; 1986 Apr; 77(16):607-12. PubMed ID: 3703359
[TBL] [Abstract][Full Text] [Related]
13. [A method of fractionating urinary peptides containing hydroxyproline].
Borel JP; Caranjot JM; Jayle MF
Clin Chim Acta; 1967 Jun; 16(3):409-16. PubMed ID: 6035187
[No Abstract] [Full Text] [Related]
14. [Urinary hydroxyproline in hyperthyroidism].
Baleva R
Vutr Boles; 1977; 16(3):64-9. PubMed ID: 898928
[TBL] [Abstract][Full Text] [Related]
15. [Chromatographic analysis of urinary amino acids in Paget's disease. II : clinical study].
Roques CF; Mazières B; Amigues H; Fournie A; Arlet J; Ruffié R
Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):255-8. PubMed ID: 1273475
[TBL] [Abstract][Full Text] [Related]
16. EXCRETION OF PYROPHOSPHATE IN DISORDERS OF BONE METABOLISM.
AVIOLI LV; MCDONALD JE; SINGER RA
J Clin Endocrinol Metab; 1965 Jul; 25():912-5. PubMed ID: 14319372
[No Abstract] [Full Text] [Related]
17. Nondialyzable urinary hydroxyproline as an index of bone collagen formation.
Haddad JG; Couranz S; Avioli LV
J Clin Endocrinol Metab; 1970 Mar; 30(3):282-7. PubMed ID: 4983851
[No Abstract] [Full Text] [Related]
18. Investigation of bone disease using isomerized and racemized fragments of type I collagen.
Cloos PA; Fledelius C; Christgau S; Christiansen C; Engsig M; Delmas P; Body JJ; Garnero P
Calcif Tissue Int; 2003 Jan; 72(1):8-17. PubMed ID: 12384813
[TBL] [Abstract][Full Text] [Related]
19. Relationship of the activity of the bone isoenzyme of serum alkaline phosphatase to urinary hydroxyproline excretion in metabolic and neoplastic bone diseases.
Stĕpán J; Pacovský V; Horn V; Silinková-Málková E; Vokrouhlická O; Konopásek B; Formánková J; Hrba J; Marek J
Eur J Clin Invest; 1978 Dec; 8(6):373-7. PubMed ID: 105909
[TBL] [Abstract][Full Text] [Related]
20. Technetium-99m-pyrophosphate kinetics and imaging in metabolic bone disease.
Rosenthall L; Kaye M
J Nucl Med; 1975 Jan; 16(1):33-9. PubMed ID: 162946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
